New cancer drugs must become available more quickly in Norway

Earlier this month, the Norwegian government launched the cancer strategy Joint Efforts Against Cancer, with five national goals and 17 new ten-year goals, which set ambitions for the cancer area up to 2035.

The new measures include eradicating cancer caused by HPV, introducing screening programs for lung cancer and prostate cancer, doubling the number of patients participating in clinical trials and business development in the field of cancer, noted the Norwegian pharma trade group LIM in a website posting.

“The pharmaceutical industry contributes many new treatments, but they have no value if they do not benefit the patient, and here we in Norway must become better at adopting new treatments more quickly. At the same time, I believe the Minister of Health deserves praise for setting goals to eradicate cervical cancer and detect lung and prostate cancer earlier,” says the LIM’s Barbara Suter.